Medicine recalls
|
| |
| Canada: Advisory - Baxter CLINIMIX, 5% Travasol Amino Acid Injection WITHOUT Electrolytes in 16.6% Dextrose Injection 1 L - Recall due to Particulate Matter Found in Solution |
| |
Baxter Corporation has initiated an Urgent Product Recall for three (3) lots (Lot Numbers: W4J03C2, W4J14C1 and W4J14C1S) of CLINIMIX, 5% Travasol Amino Acid Injection WITHOUT Electrolytes in 16.6% Dextrose Injection 1L due to particulate matter found in the solution. If infused, particulate matter could potentially lead to patient harm including phlebitis and thrombo-embolism, which could result in death. Baxter is advising all users to immediately locate and remove the affected lots from use. The affected lots should not be used and all affected inventory returned to Baxter.
Please refer to the following website in Health Canada for details:
http://www.hc-sc.gc.ca/ahc-asc/media/../clinimix-eng.php
In Hong Kong, the above product is not a registered pharmaceutical product. Related news has been released by Health Canada, and was posted on the Drug Office website on 30 May 2014.
Ends/ Monday, June 22, 2015
Issued at HKT 16:00
|
| |
|
